TY - JOUR
T1 - Extensive review based on a rare case of histiocytic sarcoma
AU - Tocut, Milena
AU - Vaknine, Hanan
AU - Potachenko, Paulina
AU - Elias, Sorin
AU - Zandman-Goddard, Gisele
N1 - Publisher Copyright:
© 2020 Israel Medical Association. All rights reserved.
PY - 2020/10
Y1 - 2020/10
N2 - Histiocytic sarcoma is a rare hematopoietic malignancy originating from the monocyte/macrophage bone marrow lineage. HS can occur in isolation or in association with other hemato-logical neoplasms such as non-Hodgkin's lymphoma, myelo-dysplasia, or acute leukemia. Clinically, HS can affect lymph nodes, gastrointestinal tract, skin, bone marrow, and spleen as well as the central nervous system. Most cases of HS follow an aggressive clinical course, with most patients dying of progressive disease within one year of diagnosis.
AB - Histiocytic sarcoma is a rare hematopoietic malignancy originating from the monocyte/macrophage bone marrow lineage. HS can occur in isolation or in association with other hemato-logical neoplasms such as non-Hodgkin's lymphoma, myelo-dysplasia, or acute leukemia. Clinically, HS can affect lymph nodes, gastrointestinal tract, skin, bone marrow, and spleen as well as the central nervous system. Most cases of HS follow an aggressive clinical course, with most patients dying of progressive disease within one year of diagnosis.
KW - Bad prognosis
KW - Bone marrow
KW - Histiocytic sarcoma
KW - Immuno-histochemistry
KW - Lymphadenopathy
UR - http://www.scopus.com/inward/record.url?scp=85093642257&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 33070490
AN - SCOPUS:85093642257
SN - 1565-1088
VL - 22
SP - 579
EP - 581
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 10
ER -